Maplelane Capital, LLC Natera, Inc. Transaction History
Maplelane Capital, LLC
- $1.64 Billion
- Q3 2024
A detailed history of Maplelane Capital, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Maplelane Capital, LLC holds 140,000 shares of NTRA stock, worth $24.5 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
140,000
Previous 140,000
-0.0%
Holding current value
$24.5 Million
Previous $15.2 Million
17.37%
% of portfolio
1.08%
Previous 0.61%
Shares
2 transactions
Others Institutions Holding NTRA
# of Institutions
529Shares Held
118MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$2 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.19 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$811 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$798 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$702 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $17B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...